Researchers at National Yang Ming Chiao Tung University (NYCU) have found that older adults with higher levels of Akkermansia muciniphila – a next-generation probiotic increasingly recognized for its health benefits – show significantly lower levels of amyloid-beta accumulation in the brain, a key biological hallmark of Alzheimer’s disease.
